Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Koopmanschap

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studiesMarc A Koopmanschap
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003
The drug budget silo mentality: the Dutch caseMarc A Koopmanschap, Frans F H Rutten
Pharmacoeconomics|March 8, 2005
The friction-cost method : replacement for nothing and leisure for free?Werner B F Brouwer, Marc A Koopmanschap
International Journal of Technology Assessment in Health Care|July 17, 2003
Cost-effectiveness analysis: can we reduce variability in costing methods?Taghreed Adam, Marc A Koopmanschap, David B Evans
International Journal of Technology Assessment in Health Care|April 16, 2010
Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionalsMarc A Koopmanschap, Elly A Stolk, Xander Koolman
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Value for money of drug regulationJacoline C Bouvy, Marc A Koopmanschap, Huub Schellekens
Drug Safety|March 31, 2015
Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesJacoline C Bouvy, Marie L De Bruin, Marc A Koopmanschap
Pharmacoeconomics|July 3, 2002
Standardisation of costs: the Dutch Manual for Costing in economic evaluationsJan B Oostenbrink, Marc A Koopmanschap, Frans F H Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic valuation of informal care. An overview of methods and applicationsBernard van den Berg, Werner B F Brouwer, Marc A Koopmanschap
Health Policy (Amsterdam, Netherlands)|May 1, 2013
Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over timeFrank G Sandmann, Margreet G Franken, Adri Steenhoek, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studiesMarc A Koopmanschap
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2003
The drug budget silo mentality: the Dutch caseMarc A Koopmanschap, Frans F H Rutten
Pharmacoeconomics|March 8, 2005
The friction-cost method : replacement for nothing and leisure for free?Werner B F Brouwer, Marc A Koopmanschap
International Journal of Technology Assessment in Health Care|July 17, 2003
Cost-effectiveness analysis: can we reduce variability in costing methods?Taghreed Adam, Marc A Koopmanschap, David B Evans
International Journal of Technology Assessment in Health Care|April 16, 2010
Dear policy maker: have you made up your mind? A discrete choice experiment among policy makers and other health professionalsMarc A Koopmanschap, Elly A Stolk, Xander Koolman
Expert Review of Pharmacoeconomics & Outcomes Research|July 21, 2012
Value for money of drug regulationJacoline C Bouvy, Marc A Koopmanschap, Huub Schellekens
Drug Safety|March 31, 2015
Epidemiology of adverse drug reactions in Europe: a review of recent observational studiesJacoline C Bouvy, Marie L De Bruin, Marc A Koopmanschap
Pharmacoeconomics|July 3, 2002
Standardisation of costs: the Dutch Manual for Costing in economic evaluationsJan B Oostenbrink, Marc A Koopmanschap, Frans F H Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic valuation of informal care. An overview of methods and applicationsBernard van den Berg, Werner B F Brouwer, Marc A Koopmanschap
Health Policy (Amsterdam, Netherlands)|May 1, 2013
Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over timeFrank G Sandmann, Margreet G Franken, Adri Steenhoek, et al.
Pageof 5